Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits
Monday, December 19, 2016 - 15:41
in Mathematics & Economics
Public funding is backing a new immunotherapy treatment, but the bulk of any profits will go to a private company. So are taxpayers getting a good deal?